Position in ABBV
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$2,167,878
+$775,073 QoQ
Shares Held
8,615
+34.5% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
1.66%
of 13F equity value
Holder Rank
#1,903
of 4,153 holders
Holding Since
Dec 2024
6 quarters on record
Voting authority
Sole 0%
Shared 49%
None 51%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026BINGHAM PRIVATE WEALTH, LLC holds $8,591,605 across 8 Drug Manufacturers - General names. ABBV ranks #1 (25.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
This page
|
8,615 | $2,167,878 | |
| 2 | GILD |
Gilead Sciences, Inc.
|
11,946 | $1,509,257 | |
| 3 | LLY |
ELI LILLY & Co
|
941 | $1,128,663 | |
| 4 | JNJ |
Johnson & Johnson
|
4,346 | $1,103,753 | |
| 5 | MRK |
Merck & Co., Inc.
|
7,105 | $912,992 | |
| 6 | AZN |
Astrazeneca PLC
|
4,104 | $778,200 | |
| 7 | AMGN |
Amgen Inc
|
1,486 | $538,110 | |
| 8 | PFE |
Pfizer Inc
|
18,802 | $452,752 |
All Filings in ABBV
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,167,878 | 8,615 | Shares | Defined | 2026-08-11 | |
| 2026-03-31 | $1,392,805 | 6,404 | Shares | Defined | 2026-05-07 | |
| 2025-12-31 | $1,146,791 | 5,019 | Shares | Defined | 2026-01-23 | |
| 2025-06-30 | $1,084,020 | 5,840 | Shares | Defined | 2025-07-23 | |
| 2025-03-31 | $1,350,984 | 6,448 | Shares | Defined | 2025-05-05 | |
| 2024-12-31 | $1,242,656 | 6,993 | Shares | Defined | 2025-05-05 | |
| No filing history on record for this holder in this stock. | ||||||